Dana G. Mordue, Ph.D.

Dana G. Mordue, Ph.D., performed her postdoctoral work with L. David Sibley, Ph.D. (National Academy of Sciences) in the Department of Molecular Microbiology at Washington University School of Medicine in St. Louis with a focus on Toxoplasma gondii cell biology and host immunity. She worked at the University of Wisconsin-Madison School of Medicine with Laura Knoll, Ph.D. to gain additional expertise in molecular biology and forward genetics.

Dr. Mordue came to New York Medical College in the School of Medicine in 2005 as an assistant professor. She is recognized for her work on host-pathogen interactions predominantly focused on the human diseases toxoplasmosis and babesiosis. Studies in Dr. Mordue's laboratory integrate microbiology, immunology, cell biology, and systems biology and our funded by the National Institute of Health and the Department of Defense. Current studies are focused on translational research aimed at understanding key host and pathogen determinants that underlie differences in disease severity in babesiosis. Dr. Mordue was the PI on a National Institute of Health Shared Instrumentation Grant in 2020 that resulted in an award to NYMC for a state-of-the-art Zeiss LSM 980 plus Airyscan II Confocal System and is the assistant director for the NYMC Histopathology and Immunology Core where the new instrument is housed.

Dr. Mordue has served as a leader in faculty governance at NYMC for more than 15 years and received multiple teaching awards from SOM and GSBMS students. Additional administrative service includes chair and co-chair for strategic planning initiatives, interim dean for the NYMC GSBMS, vice chancellor for MSCHE Accreditation, and currently vice chancellor for NYMC accreditation and student support.